However, these strategies led to CDN uptake in only a small fraction of cancer cells or tumour-infiltrating immune cells (∼2–10%)14,16, which may reflect their limited ability to diffuse through the dense tumour extracellular matrix (ECM) and propensity for clearance by the reticuloendothelial system. Here, NT5C is linked to cancer.